Metabolomics of Plasma in XLH Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms Article Swipe
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3390/ijms25063545
X-linked hypophosphatemia (XLH) is a rare genetic disorder that increases fibroblast growth factor 23 (FGF23). XLH patients have an elevated risk of early-onset hypertension. The precise factors contributing to hypertension in XLH patients have yet to be identified. A multicenter cross-sectional study of adult patients diagnosed with XLH. Metabolomic analysis was performed using ultra-performance liquid chromatography (UPLC) coupled to a high-resolution mass spectrometer. Twenty subjects were included, of which nine (45%) had hypertension. The median age was 44 years. Out of the total, seven (35%) subjects had a family history of hypertension. No statistically significant differences were found between both groups for nephrocalcinosis or hyperparathyroidism. Those with hypertension exhibited significantly higher levels of creatinine (1.08 ± 0.31 mg/dL vs. 0.78 ± 0.19 mg/dL; p = 0.01) and LDL-C (133.33 ± 21.92 mg/dL vs. 107.27 ± 20.12 mg/dL, p = 0.01). A total of 106 metabolites were identified. Acetylcarnitine (p = 0.03), pyruvate p = (0.04), ethanolamine (p = 0.03), and butyric acid (p = 0.001) were significantly different between both groups. This study is the first to examine the metabolomics of hypertension in patients with XLH. We have identified significant changes in specific metabolites that shed new light on the potential mechanisms of hypertension in XLH patients. These findings could lead to new studies identifying associated biomarkers and developing new diagnostic approaches for XLH patients.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3390/ijms25063545
- https://www.mdpi.com/1422-0067/25/6/3545/pdf?version=1711016834
- OA Status
- gold
- Cited By
- 3
- References
- 37
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4393044502
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4393044502Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/ijms25063545Digital Object Identifier
- Title
-
Metabolomics of Plasma in XLH Patients with Arterial Hypertension: New Insights into the Underlying MechanismsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-03-21Full publication date if available
- Authors
-
Luis Carlos López-Romero, José Jesús Broseta, Marta Roca, Juan R. Muñoz‐Castañeda, Agustín Lahoz, Julio Hernández JarasList of authors in order
- Landing page
-
https://doi.org/10.3390/ijms25063545Publisher landing page
- PDF URL
-
https://www.mdpi.com/1422-0067/25/6/3545/pdf?version=1711016834Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.mdpi.com/1422-0067/25/6/3545/pdf?version=1711016834Direct OA link when available
- Concepts
-
Internal medicine, Medicine, Endocrinology, Hypophosphatemia, Creatinine, GastroenterologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 2Per-year citation counts (last 5 years)
- References (count)
-
37Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4393044502 |
|---|---|
| doi | https://doi.org/10.3390/ijms25063545 |
| ids.doi | https://doi.org/10.3390/ijms25063545 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38542517 |
| ids.openalex | https://openalex.org/W4393044502 |
| fwci | 2.12050682 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000235 |
| mesh[2].descriptor_ui | D053098 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | genetics |
| mesh[2].descriptor_name | Familial Hypophosphatemic Rickets |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D003430 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Cross-Sectional Studies |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006973 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Hypertension |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D005346 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Fibroblast Growth Factors |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D000328 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Adult |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | Q000235 |
| mesh[8].descriptor_ui | D053098 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | genetics |
| mesh[8].descriptor_name | Familial Hypophosphatemic Rickets |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D003430 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Cross-Sectional Studies |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006973 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Hypertension |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D005346 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Fibroblast Growth Factors |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000328 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Adult |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D006801 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Humans |
| mesh[14].qualifier_ui | Q000235 |
| mesh[14].descriptor_ui | D053098 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | genetics |
| mesh[14].descriptor_name | Familial Hypophosphatemic Rickets |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D003430 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Cross-Sectional Studies |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006973 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Hypertension |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D005346 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Fibroblast Growth Factors |
| type | article |
| title | Metabolomics of Plasma in XLH Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms |
| biblio.issue | 6 |
| biblio.volume | 25 |
| biblio.last_page | 3545 |
| biblio.first_page | 3545 |
| topics[0].id | https://openalex.org/T10516 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2727 |
| topics[0].subfield.display_name | Nephrology |
| topics[0].display_name | Parathyroid Disorders and Treatments |
| topics[1].id | https://openalex.org/T12287 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9944999814033508 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Fibroblast Growth Factor Research |
| topics[2].id | https://openalex.org/T11339 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9937999844551086 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Metabolism, Diabetes, and Cancer |
| is_xpac | False |
| apc_list.value | 2300 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2490 |
| apc_paid.value | 2300 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2490 |
| concepts[0].id | https://openalex.org/C126322002 |
| concepts[0].level | 1 |
| concepts[0].score | 0.6437827944755554 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[0].display_name | Internal medicine |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5283055305480957 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C134018914 |
| concepts[2].level | 1 |
| concepts[2].score | 0.49154743552207947 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[2].display_name | Endocrinology |
| concepts[3].id | https://openalex.org/C2778573388 |
| concepts[3].level | 2 |
| concepts[3].score | 0.46152937412261963 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1641384 |
| concepts[3].display_name | Hypophosphatemia |
| concepts[4].id | https://openalex.org/C2780306776 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4434290826320648 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q426660 |
| concepts[4].display_name | Creatinine |
| concepts[5].id | https://openalex.org/C90924648 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3940955400466919 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[5].display_name | Gastroenterology |
| keywords[0].id | https://openalex.org/keywords/internal-medicine |
| keywords[0].score | 0.6437827944755554 |
| keywords[0].display_name | Internal medicine |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.5283055305480957 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/endocrinology |
| keywords[2].score | 0.49154743552207947 |
| keywords[2].display_name | Endocrinology |
| keywords[3].id | https://openalex.org/keywords/hypophosphatemia |
| keywords[3].score | 0.46152937412261963 |
| keywords[3].display_name | Hypophosphatemia |
| keywords[4].id | https://openalex.org/keywords/creatinine |
| keywords[4].score | 0.4434290826320648 |
| keywords[4].display_name | Creatinine |
| keywords[5].id | https://openalex.org/keywords/gastroenterology |
| keywords[5].score | 0.3940955400466919 |
| keywords[5].display_name | Gastroenterology |
| language | en |
| locations[0].id | doi:10.3390/ijms25063545 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S10623703 |
| locations[0].source.issn | 1422-0067, 1661-6596 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1422-0067 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | International Journal of Molecular Sciences |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.mdpi.com/1422-0067/25/6/3545/pdf?version=1711016834 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Journal of Molecular Sciences |
| locations[0].landing_page_url | https://doi.org/10.3390/ijms25063545 |
| locations[1].id | pmid:38542517 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | International journal of molecular sciences |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38542517 |
| locations[2].id | pmh:oai:mdpi.com:/1422-0067/25/6/3545/ |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400947 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | True |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | MDPI (MDPI AG) |
| locations[2].source.host_organization | https://openalex.org/I4210097602 |
| locations[2].source.host_organization_name | Multidisciplinary Digital Publishing Institute (Switzerland) |
| locations[2].source.host_organization_lineage | https://openalex.org/I4210097602 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | International Journal of Molecular Sciences |
| locations[2].landing_page_url | https://dx.doi.org/10.3390/ijms25063545 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:10971556 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Int J Mol Sci |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10971556 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5080889495 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5986-8811 |
| authorships[0].author.display_name | Luis Carlos López-Romero |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210127649 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Nephrology, Consorci Hospital General Universitari de València, 46014 Valencia, Spain |
| authorships[0].institutions[0].id | https://openalex.org/I4210127649 |
| authorships[0].institutions[0].ror | https://ror.org/03sz8rb35 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210127649 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Hospital General Universitario De Valencia |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Luis Carlos López-Romero |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Nephrology, Consorci Hospital General Universitari de València, 46014 Valencia, Spain |
| authorships[1].author.id | https://openalex.org/A5022120521 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4559-9083 |
| authorships[1].author.display_name | José Jesús Broseta |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, 08036 Barcelona, Spain |
| authorships[1].institutions[0].id | https://openalex.org/I4210115097 |
| authorships[1].institutions[0].ror | https://ror.org/02a2kzf50 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210115097 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Hospital Clínic de Barcelona |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | José Jesús Broseta |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, 08036 Barcelona, Spain |
| authorships[2].author.id | https://openalex.org/A5062095706 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0708-6364 |
| authorships[2].author.display_name | Marta Roca |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210166036 |
| authorships[2].affiliations[0].raw_affiliation_string | Metabolomics Unit, Health Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I4210166036 |
| authorships[2].institutions[0].ror | https://ror.org/05n7v5997 |
| authorships[2].institutions[0].type | nonprofit |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210166036 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Instituto de Investigación Sanitaria La Fe |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Marta Roca-Marugán |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Metabolomics Unit, Health Research Institute Hospital La Fe (IIS La Fe), 46026 Valencia, Spain |
| authorships[3].author.id | https://openalex.org/A5089097452 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9341-0724 |
| authorships[3].author.display_name | Juan R. Muñoz‐Castañeda |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210093628, https://openalex.org/I4210123675, https://openalex.org/I53110688 |
| authorships[3].affiliations[0].raw_affiliation_string | Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Nephrology Clinical Management Unit, Reina Sofia Hospital/University of Cordoba, 14071 Córdoba, Spain |
| authorships[3].institutions[0].id | https://openalex.org/I4210123675 |
| authorships[3].institutions[0].ror | https://ror.org/02vtd2q19 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I158283456, https://openalex.org/I4210123675 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Hospital Universitario Reina Sofía |
| authorships[3].institutions[1].id | https://openalex.org/I4210093628 |
| authorships[3].institutions[1].ror | https://ror.org/00j9b6f88 |
| authorships[3].institutions[1].type | facility |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210093628 |
| authorships[3].institutions[1].country_code | ES |
| authorships[3].institutions[1].display_name | Instituto Maimónides de Investigación Biomédica de Córdoba |
| authorships[3].institutions[2].id | https://openalex.org/I53110688 |
| authorships[3].institutions[2].ror | https://ror.org/05yc77b46 |
| authorships[3].institutions[2].type | education |
| authorships[3].institutions[2].lineage | https://openalex.org/I53110688 |
| authorships[3].institutions[2].country_code | ES |
| authorships[3].institutions[2].display_name | University of Córdoba |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Juan R. Muñoz-Castañeda |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Nephrology Clinical Management Unit, Reina Sofia Hospital/University of Cordoba, 14071 Córdoba, Spain |
| authorships[4].author.id | https://openalex.org/A5083933505 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7232-0626 |
| authorships[4].author.display_name | Agustín Lahoz |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210121834 |
| authorships[4].affiliations[0].raw_affiliation_string | Biomarkers and Precision Medicine Unit, Health Research Institute-Hospital La Fe, 46026 Valencia, Spain |
| authorships[4].institutions[0].id | https://openalex.org/I4210121834 |
| authorships[4].institutions[0].ror | https://ror.org/02njs1t69 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210121834 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Leitat Technological Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Agustín Lahoz |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Biomarkers and Precision Medicine Unit, Health Research Institute-Hospital La Fe, 46026 Valencia, Spain |
| authorships[5].author.id | https://openalex.org/A5079747251 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1250-1550 |
| authorships[5].author.display_name | Julio Hernández Jaras |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I3019010403 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Nephrology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain |
| authorships[5].institutions[0].id | https://openalex.org/I3019010403 |
| authorships[5].institutions[0].ror | https://ror.org/01ar2v535 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I3019010403, https://openalex.org/I4210166036 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Hospital Universitari i Politècnic La Fe |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Julio Hernández-Jaras |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Nephrology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.mdpi.com/1422-0067/25/6/3545/pdf?version=1711016834 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Metabolomics of Plasma in XLH Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10516 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2727 |
| primary_topic.subfield.display_name | Nephrology |
| primary_topic.display_name | Parathyroid Disorders and Treatments |
| related_works | https://openalex.org/W1979139803, https://openalex.org/W1966504330, https://openalex.org/W2037631372, https://openalex.org/W4252436151, https://openalex.org/W2030889776, https://openalex.org/W1966775726, https://openalex.org/W1974041167, https://openalex.org/W1984079239, https://openalex.org/W4249176446, https://openalex.org/W2391409986 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3390/ijms25063545 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S10623703 |
| best_oa_location.source.issn | 1422-0067, 1661-6596 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1422-0067 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | International Journal of Molecular Sciences |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.mdpi.com/1422-0067/25/6/3545/pdf?version=1711016834 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Journal of Molecular Sciences |
| best_oa_location.landing_page_url | https://doi.org/10.3390/ijms25063545 |
| primary_location.id | doi:10.3390/ijms25063545 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S10623703 |
| primary_location.source.issn | 1422-0067, 1661-6596 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1422-0067 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | International Journal of Molecular Sciences |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.mdpi.com/1422-0067/25/6/3545/pdf?version=1711016834 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Journal of Molecular Sciences |
| primary_location.landing_page_url | https://doi.org/10.3390/ijms25063545 |
| publication_date | 2024-03-21 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2920227719, https://openalex.org/W4288046049, https://openalex.org/W2565532500, https://openalex.org/W1525587039, https://openalex.org/W2167995070, https://openalex.org/W2563940002, https://openalex.org/W2899736836, https://openalex.org/W2615547515, https://openalex.org/W4239096779, https://openalex.org/W2162006322, https://openalex.org/W2413140984, https://openalex.org/W2799504484, https://openalex.org/W3005411776, https://openalex.org/W4249433407, https://openalex.org/W2915280035, https://openalex.org/W2115179369, https://openalex.org/W2337352325, https://openalex.org/W3195408281, https://openalex.org/W3086642106, https://openalex.org/W2901993689, https://openalex.org/W4220810874, https://openalex.org/W1968583683, https://openalex.org/W2122367003, https://openalex.org/W1988919465, https://openalex.org/W2972732013, https://openalex.org/W2100461885, https://openalex.org/W3013726073, https://openalex.org/W2780050042, https://openalex.org/W2130424628, https://openalex.org/W2988881493, https://openalex.org/W4311138401, https://openalex.org/W3125196982, https://openalex.org/W4392777592, https://openalex.org/W3023443595, https://openalex.org/W2067669340, https://openalex.org/W2770837559, https://openalex.org/W4200071733 |
| referenced_works_count | 37 |
| abstract_inverted_index.= | 124, 138, 149, 153, 157, 163 |
| abstract_inverted_index.A | 38, 140 |
| abstract_inverted_index.a | 4, 59, 87 |
| abstract_inverted_index.p | 123, 137, 152 |
| abstract_inverted_index.(p | 148, 156, 162 |
| abstract_inverted_index.23 | 13 |
| abstract_inverted_index.44 | 77 |
| abstract_inverted_index.No | 92 |
| abstract_inverted_index.We | 186 |
| abstract_inverted_index.an | 18 |
| abstract_inverted_index.be | 36 |
| abstract_inverted_index.in | 30, 182, 191, 204 |
| abstract_inverted_index.is | 3, 173 |
| abstract_inverted_index.of | 21, 42, 67, 80, 90, 112, 142, 180, 202 |
| abstract_inverted_index.on | 198 |
| abstract_inverted_index.or | 103 |
| abstract_inverted_index.to | 28, 35, 58, 176, 211 |
| abstract_inverted_index.± | 115, 120, 129, 134 |
| abstract_inverted_index.106 | 143 |
| abstract_inverted_index.Out | 79 |
| abstract_inverted_index.The | 24, 73 |
| abstract_inverted_index.XLH | 15, 31, 205, 223 |
| abstract_inverted_index.age | 75 |
| abstract_inverted_index.and | 126, 159, 217 |
| abstract_inverted_index.for | 101, 222 |
| abstract_inverted_index.had | 71, 86 |
| abstract_inverted_index.new | 196, 212, 219 |
| abstract_inverted_index.the | 81, 174, 178, 199 |
| abstract_inverted_index.vs. | 118, 132 |
| abstract_inverted_index.was | 50, 76 |
| abstract_inverted_index.yet | 34 |
| abstract_inverted_index.0.19 | 121 |
| abstract_inverted_index.0.31 | 116 |
| abstract_inverted_index.0.78 | 119 |
| abstract_inverted_index.This | 171 |
| abstract_inverted_index.XLH. | 47, 185 |
| abstract_inverted_index.acid | 161 |
| abstract_inverted_index.both | 99, 169 |
| abstract_inverted_index.have | 17, 33, 187 |
| abstract_inverted_index.lead | 210 |
| abstract_inverted_index.mass | 61 |
| abstract_inverted_index.nine | 69 |
| abstract_inverted_index.rare | 5 |
| abstract_inverted_index.risk | 20 |
| abstract_inverted_index.shed | 195 |
| abstract_inverted_index.that | 8, 194 |
| abstract_inverted_index.were | 65, 96, 145, 165 |
| abstract_inverted_index.with | 46, 106, 184 |
| abstract_inverted_index.(1.08 | 114 |
| abstract_inverted_index.(35%) | 84 |
| abstract_inverted_index.(45%) | 70 |
| abstract_inverted_index.(XLH) | 2 |
| abstract_inverted_index.0.01) | 125 |
| abstract_inverted_index.20.12 | 135 |
| abstract_inverted_index.21.92 | 130 |
| abstract_inverted_index.LDL-C | 127 |
| abstract_inverted_index.These | 207 |
| abstract_inverted_index.Those | 105 |
| abstract_inverted_index.adult | 43 |
| abstract_inverted_index.could | 209 |
| abstract_inverted_index.first | 175 |
| abstract_inverted_index.found | 97 |
| abstract_inverted_index.light | 197 |
| abstract_inverted_index.mg/dL | 117, 131 |
| abstract_inverted_index.seven | 83 |
| abstract_inverted_index.study | 41, 172 |
| abstract_inverted_index.total | 141 |
| abstract_inverted_index.using | 52 |
| abstract_inverted_index.which | 68 |
| abstract_inverted_index.(UPLC) | 56 |
| abstract_inverted_index.0.001) | 164 |
| abstract_inverted_index.0.01). | 139 |
| abstract_inverted_index.0.03), | 150, 158 |
| abstract_inverted_index.107.27 | 133 |
| abstract_inverted_index.Twenty | 63 |
| abstract_inverted_index.factor | 12 |
| abstract_inverted_index.family | 88 |
| abstract_inverted_index.groups | 100 |
| abstract_inverted_index.growth | 11 |
| abstract_inverted_index.higher | 110 |
| abstract_inverted_index.levels | 111 |
| abstract_inverted_index.liquid | 54 |
| abstract_inverted_index.median | 74 |
| abstract_inverted_index.mg/dL, | 136 |
| abstract_inverted_index.mg/dL; | 122 |
| abstract_inverted_index.total, | 82 |
| abstract_inverted_index.years. | 78 |
| abstract_inverted_index.(0.04), | 154 |
| abstract_inverted_index.(133.33 | 128 |
| abstract_inverted_index.between | 98, 168 |
| abstract_inverted_index.butyric | 160 |
| abstract_inverted_index.changes | 190 |
| abstract_inverted_index.coupled | 57 |
| abstract_inverted_index.examine | 177 |
| abstract_inverted_index.factors | 26 |
| abstract_inverted_index.genetic | 6 |
| abstract_inverted_index.groups. | 170 |
| abstract_inverted_index.history | 89 |
| abstract_inverted_index.precise | 25 |
| abstract_inverted_index.studies | 213 |
| abstract_inverted_index.(FGF23). | 14 |
| abstract_inverted_index.X-linked | 0 |
| abstract_inverted_index.analysis | 49 |
| abstract_inverted_index.disorder | 7 |
| abstract_inverted_index.elevated | 19 |
| abstract_inverted_index.findings | 208 |
| abstract_inverted_index.patients | 16, 32, 44, 183 |
| abstract_inverted_index.pyruvate | 151 |
| abstract_inverted_index.specific | 192 |
| abstract_inverted_index.subjects | 64, 85 |
| abstract_inverted_index.diagnosed | 45 |
| abstract_inverted_index.different | 167 |
| abstract_inverted_index.exhibited | 108 |
| abstract_inverted_index.included, | 66 |
| abstract_inverted_index.increases | 9 |
| abstract_inverted_index.patients. | 206, 224 |
| abstract_inverted_index.performed | 51 |
| abstract_inverted_index.potential | 200 |
| abstract_inverted_index.approaches | 221 |
| abstract_inverted_index.associated | 215 |
| abstract_inverted_index.biomarkers | 216 |
| abstract_inverted_index.creatinine | 113 |
| abstract_inverted_index.developing | 218 |
| abstract_inverted_index.diagnostic | 220 |
| abstract_inverted_index.fibroblast | 10 |
| abstract_inverted_index.identified | 188 |
| abstract_inverted_index.mechanisms | 201 |
| abstract_inverted_index.Metabolomic | 48 |
| abstract_inverted_index.differences | 95 |
| abstract_inverted_index.early-onset | 22 |
| abstract_inverted_index.identified. | 37, 146 |
| abstract_inverted_index.identifying | 214 |
| abstract_inverted_index.metabolites | 144, 193 |
| abstract_inverted_index.multicenter | 39 |
| abstract_inverted_index.significant | 94, 189 |
| abstract_inverted_index.contributing | 27 |
| abstract_inverted_index.ethanolamine | 155 |
| abstract_inverted_index.hypertension | 29, 107, 181, 203 |
| abstract_inverted_index.metabolomics | 179 |
| abstract_inverted_index.hypertension. | 23, 72, 91 |
| abstract_inverted_index.significantly | 109, 166 |
| abstract_inverted_index.spectrometer. | 62 |
| abstract_inverted_index.statistically | 93 |
| abstract_inverted_index.chromatography | 55 |
| abstract_inverted_index.Acetylcarnitine | 147 |
| abstract_inverted_index.cross-sectional | 40 |
| abstract_inverted_index.high-resolution | 60 |
| abstract_inverted_index.hypophosphatemia | 1 |
| abstract_inverted_index.nephrocalcinosis | 102 |
| abstract_inverted_index.ultra-performance | 53 |
| abstract_inverted_index.hyperparathyroidism. | 104 |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 91 |
| corresponding_author_ids | https://openalex.org/A5080889495 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I4210127649 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6399999856948853 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.80669694 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |